Skip to main content
OpenTrials
Completed

NCT Number: NCT04409249

Prognosis in Pregnant With COVID-19

COVID-19 is a disease whose development, prognosis mechanism and immune status are still unknown. The aim of the study is to determine the relationship between clinical and laboratory data and the severity of the disease by evaluating the hematological and radiological features of the patients. The secondary aim is to determine the predictive values of clinical and laboratory data for the severity of COVID-19.

Completed

Looking for future studies?

Notify Me

Key information

Age range

18 year–45 year

Sex eligibility

Female

Study type

Observational

Primary location

Kanuni Sultan Suleyman Training and Research Hospital

Istanbul, Halkali, 34307, Turkey (Türkiye)

Who can participate

Only the study team can determine whether someone qualifies for participation.

Inclusion criteria

  • Being pregnant with a diagnosis of COVID-19 between the ages of 18-45

Exclusion criteria

  • Suspected COVID-19 diagnosis

Treatment and study plan

imaging, blood tests

Diagnostic Test

PCR and CT results, hemogram, urea, creatinine, AST, ALT, LDH, D-Dimer, ferritin, lipase, amylase, CRP, procalcitonin, albumin, total protein, coagulation tests-PT, APTT, Fibrinogen-, Troponin T, CK , electrolytes, blood gas, bilirubins

Primary outcomes

  1. the factors affecting prognosis in pregnant women diagnosed with COVID-19

    Time frame: 3 Months

Sponsors and collaborators

Lead sponsor

Kanuni Sultan Suleyman Training and Research Hospital

Other

Registry information

Official study title

Prognostic Factors in Pregnant Women With COVID-19

Important dates

Study start
2020
Primary completion
2020
Study completion
2020
First posted
Jun 1, 2020
Registry last updated
Jul 2, 2020

OpenTrials presents study information sourced from ClinicalTrials.gov. The official registry record should be consulted for the latest information.

View the official ClinicalTrials.gov record (opens in a new tab)

This listing is for discovery and informational purposes only. It is not medical advice, does not guarantee that a study is recruiting, and does not determine eligibility. Contact the study team and a qualified healthcare professional when considering participation.

Published trials that share one or more normalized conditions with this study.